Literature DB >> 31215352

Use of Behavioral Economics to Improve Medication Adherence in Severe Mental Illness.

Daniel Guinart1, John M Kane1.   

Abstract

Medication nonadherence is associated with multiple negative outcomes. Financial reinforcement based on behavioral economic principles has been proposed as a potential strategy to enhance medication adherence in severe mental illness, and some studies show that small incentives significantly increase adherence to long-acting injectable treatment. After the intervention is stopped, however, adherence appears to decline. Because of the limited number of studies published so far, results should be interpreted with caution. When implementing this strategy, measures must be taken to address ethical concerns. Larger, naturalistic studies focusing on the effects of financial incentives for different treatment formulations are needed to further evaluate this adherence-enhancing strategy.

Entities:  

Keywords:  Adherence; Psychiatry/general; behavioral economics; psychiatry; psychosis; schizophrenia

Year:  2019        PMID: 31215352     DOI: 10.1176/appi.ps.201900116

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  3 in total

1.  Choice architecture-based prescribing tool for TB preventive therapy: a pilot study in South Africa.

Authors:  G Caturegli; J Materi; A Lombardo; M Milovanovic; N Yende; E Variava; J E Golub; N A Martinson; C J Hoffmann
Journal:  Public Health Action       Date:  2020-09-21

2.  Can incentives improve antipsychotic adherence in major mental illness? A mixed-methods systematic review.

Authors:  Nathan Hodson; Madiha Majid; Ivo Vlaev; Swaran Preet Singh
Journal:  BMJ Open       Date:  2022-06-15       Impact factor: 3.006

Review 3.  Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia.

Authors:  John M Kane; Joseph P McEvoy; Christoph U Correll; Pierre-Michel Llorca
Journal:  CNS Drugs       Date:  2021-10-11       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.